AbbVie Reports Promising Clinical Updates, Dividend Outlook
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
Incorporating alternative investments into your long-term portfolio can enhance diversification and improve returns.
27,567 articlesAbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
Claude AI’s world predictions for two World Cup matches produced a mixed bag: a precise call in USA vs Australia and ...
Hyperliquid's native token continues a sharp weekly decline, reviving bearish bets as traders weigh on-chain signals ...
President Trump urges a DOJ review into potential oil pricing abuses as wholesale costs fall but pump prices lag. The...
Institutional demand for Solana ETFs has reached about $540 million across roughly 30 institutions, even as SOL trade...
A renewed memory cycle could reshape profits for big chip players. This deep dive explains why Micron's latest update...
Markets swing, but smart investors seek durable growth. This article highlights three names with a credible path to m...
The passing of kenyan tiktoker malon kiptarus at Dubai’s Jumeirah Beach shines a light on money matters for expats. T...
New budget estimates warn that a rapid U.S. operation in Iran could add about $65 billion to the national debt over t...
Intel pursues a renewed foundry strategy and AI-focused growth as investors weigh the company’s turnaround. The marke...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
MicroStrategy remains tethered to Bitcoin moves, but bullish bets persist as the company expands its digital-asset st...